Abstract
One of the most important findings of the recent years is that bone remodeling is under control of the central nervous system (SNC), with the sympathetic nervous system (SNS) acting as the peripheral effector. A series of studies suggest that the SNS negatively regulates bone mass, acting exclusively via beta2-adrenoceptor (B2-AR), which is expressed in osteoblasts. However, a recent stud…